Investigation of Autosomal Genetic Sex Differences in Parkinsons disease
Cornelis BlauwendraatiD, Hirotaka IwakiiD, Mary B. MakariousiD, Sara Bandrés‐CigaiD, Hampton L. LeonardiD, Francis P. Grenn, Julie LakeiD, Lynne KrohniD, Manuela M. X. TaniD, Jonggeol Jeffrey KimiD, Jesse Raphael GibbsiD, Dena G. HernandeziD, Jennifer A. RuskeyiD, Lasse PihlstrømiD, Mathias ToftiD, Jacobus Johannes van HilteniD, Johan MarinusiD, Claudia SchulteiD, Kathrin BrockmanniD, Manu SharmaiD, Ari SiitoneniD, Kari MajamaaiD, Johanna Eerola‐Rautio, Pentti J. TienariiD, Donald G. GrossetiD, , Andrew SingletoniD
Abstract
Parkinsons disease (PD) is a complex neurodegenerative disorder. Males are on average [~]1.5 times more likely to develop PD compared to females. Over the years genome-wide association studies (GWAS) have identified numerous genetic risk factors for PD, however it is unclear whether genetics contribute to disease etiology in a sex-specific manner. In an effort to study sex-specific genetic factors associated with PD, we explored two large genetic datasets from the International Parkinsons Disease Genomics Consortium and the UK Biobank consisting of 13,020 male PD cases, 7,936 paternal proxy cases, 89,660 male controls, 7,947 female PD cases, 5,473 maternal proxy cases and 90,662 female controls. We performed GWAS meta-analyses to identify distinct patterns of genetic risk contributing to disease in male versus female PD cases. In total 19 genome-wide significant regions were identified, and no sex-specific effects were observed. A high genetic correlation between the male and female PD GWASes was identified (rg=0.877) and heritability estimates were identical between male and female PD cases ([~]20%). We did not detect any significant genetic differences between male or female PD cases. Our study does not support the notion that common genetic variation on the autosomes could explain the difference in prevalence of PD between males and females at least when considering the current sample size under study. Further studies are warranted to investigate the genetic architecture of PD explained by X and Y chromosomes and further evaluate environmental effects that could potentially contribute to PD etiology in male versus females.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 65
- FWCI
- 4.91
- Field percentile
- top 4%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Shared and Sex-Specific Genetic Risk for Parkinson's Disease Risk Across European Populations
the Global Parkinson’s Genetic Program (GP2), Hampton L. Leonard·medRxiv·Jan 2, 2026
- Sex-Stratified Multi-Omics Identifies Sexually Dimorphic Molecular Targets in Parkinsons Disease
Joo-Yeon Lee, Jimin Lee, … Joohon Sung·medRxiv·Apr 13, 2026
- Analysis of Y Chromosome Haplogroups in Parkinson's Disease
Francis P. Grenn, Mary B. Makarious, … Cornelis Blauwendraat·Brain CommunicationsPeer-reviewed·Oct 28, 2022
- Expanding Parkinson’s disease genetics: novel risk loci, genomic context, causal insights and heritable risk
Mike A. Nalls, Cornelis Blauwendraat, … Ciara García·The Lancet NeurologyPeer-reviewed·Nov 6, 2019
- X-Chromosome Association Study in Latin American Cohorts Identifies New Loci in Parkinson Disease
Thiago Peixoto Leal, Jennifer N. French, … Ignacio Fernandez Mata·medRxiv·Jan 31, 2023
- Unveiling Sex-based Differences in Parkinson's Disease: A Comprehensive Meta-analysis of Transcriptomic Studies
Adolfo López‐Cerdán, Zoraida Andreu, … Francisco Garcia‐García·Biology of Sex DifferencesPeer-reviewed·Nov 22, 2022